According to RIA Novosti report, Veronika Skvortsova, the head of the FMBA, statedthe FMBA is presenting two new drugs for leprosy and malaria at the exhibition of the Army-2022 forum.
She noted that the focus of FMBA work is not import substitution but on keeping ahead of imports, creating domestic technologies based on its own know-how. “Today we are showing two new drugs, against leprosy and malaria, at the exhibition,” Skvortsova said in an interview.
She also said that clinical trials of the Mir-19 coronavirus drug for outpatient use have been completed, and the drug may appear on the market at the end of August.
“They have been completed. We are now making a report to expand the indications for use. Currently, this work is underway, and we may hope that it will come in the market at the end of August,” Skvortsova told reporters answering a question about how the research on Mir–19 drug for outpatient use was going.
